Published in Anticancer Res on September 01, 2012
Chemotherapy and resection for gastric cancer with synchronous liver metastases. World J Gastroenterol (2013) 0.89
Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma. Therap Adv Gastroenterol (2015) 0.80
Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer. World J Gastrointest Surg (2016) 0.75
Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study. World J Gastroenterol (2017) 0.75
Impact of the availability of active cytotoxic agents on the survival of patients with advanced gastric cancer. Oncol Lett (2015) 0.75
Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer. JOP (2008) 2.39
Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest (2009) 1.80
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
The role of angiogenesis in solid tumours: an overview. Eur J Intern Med (2009) 1.72
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol (2005) 1.69
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer. J Clin Oncol (2012) 1.52
Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J Gastroenterol Hepatol (2013) 1.33
TGF-beta signalling in colon carcinogenesis. Cancer Lett (2011) 1.26
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Bile duct injuries associated with laparoscopic and open cholecystectomy: an 11-year experience in one institute. Surg Today (2005) 1.18
Amyand's hernia: a case report. World J Gastroenterol (2006) 1.11
Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis. Anticancer Res (2008) 1.10
Emergency liver resection for combined biliary and vascular injury following laparoscopic cholecystectomy: case report and review of the literature. South Med J (2007) 1.09
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG). Breast Cancer Res Treat (2009) 1.08
Clinical implications of small bowel diverticula. Isr Med Assoc J (2002) 1.08
The role of abdominal imaging in cases with a high probability of acute left-sided colonic diverticulitis based on a clinical scoring system. Ann Surg (2013) 1.07
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Hypersensitivity reactions to oxaliplatin and other antineoplastic agents. Curr Allergy Asthma Rep (2008) 1.05
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Laparoscopic gastric plication for the treatment of morbid obesity: a review. Minim Invasive Surg (2012) 1.03
Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res (2010) 1.02
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
Two-trocar laparoscopic-assisted appendectomy versus conventional laparoscopic appendectomy in patients with acute appendicitis. J Laparoendosc Adv Surg Tech A (2006) 1.02
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis (2012) 1.01
Developments in the treatment of non-small cell lung cancer. Anticancer Res (2007) 1.01
E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res (2004) 1.00
Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. Eur J Clin Invest (2011) 1.00
A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer. BMC Cancer (2010) 0.99
Role and cost effectiveness of PET/CT in management of patients with cancer. Yale J Biol Med (2010) 0.97
Capsule endoscopy in the investigation of patients with portal hypertension and anemia. Can J Gastroenterol (2008) 0.97
Erlotinib-induced skin rash. Pathogenesis, clinical significance and management in pancreatic cancer patients. JOP (2008) 0.97
Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96
Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study. Oncology (2006) 0.95
Targeted (and chemotherapeutic) agents as maintenance treatment in patients with metastatic non-small-cell lung cancer: current status and future challenges. Cancer Treat Rev (2012) 0.94
Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience. Oncology (2008) 0.94
Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer Res (2010) 0.93
Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93
OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Mol Carcinog (2011) 0.93
Lingual and facial arteries arising from the external carotid artery in a common trunk. Am Surg (2011) 0.92
Coexistence of hepatocellular carcinoma (HCC) and c-Kit negative gastrointestinal stromal tumor (GIST): a case report. South Med J (2008) 0.92
Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients. Head Neck (2013) 0.92
Morbid obesity and sleeve gastrectomy: how does it work? Obes Surg (2010) 0.92
The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds (2013) 0.91
Reliability of panoramic radiograph for carotid atheroma detection: a study in patients who fulfill the criteria for carotid endarterectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.91
Bisphosphonate use in patients with lung cancer and bone metastases: recommendations of a European expert panel. J Thorac Oncol (2009) 0.90
True giant common hepatic artery aneurysm associated with obstructive jaundice: a case report. Int Surg (2002) 0.90
Genetic alterations in pancreatic cancer. World J Gastroenterol (2007) 0.89
Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Mod Pathol (2003) 0.89
Gastrointestinal stromal tumors (GISTs): an updated experience. Dig Dis Sci (2010) 0.89
Metastatic melanoma in the gallbladder: report of a case. Surg Today (2003) 0.88
Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study. Anticancer Res (2010) 0.88
Giant pedunculated hepatocellular carcinoma with hemangioma mimicking intestinal obstruction. BMC Gastroenterol (2011) 0.88
Differential effect of Pistacia vera extracts on experimental atherosclerosis in the rabbit animal model: an experimental study. Lipids Health Dis (2010) 0.87
Heat shock protein inhibitors and vaccines as new agents in cancer treatment. Expert Opin Investig Drugs (2009) 0.87
Deconstructing laparoscopic competence in a virtual reality simulation environment. Surgery (2011) 0.87
Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer. Tumour Biol (2012) 0.86
Quantum dots hold promise for early cancer imaging and detection. Int J Cancer (2012) 0.86
Genetic association studies in digestive system malignancies. Anticancer Res (2007) 0.86
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial. Lung Cancer (2007) 0.85
Global financial crisis and surgical practice: the Greek paradigm. World J Surg (2011) 0.85
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) IN GI MALIGNANCIES: EXPERIENCE OF 4-YEARS. Pak J Med Sci (2007) 0.85
Laparoscopic adrenalectomy: where do we stand now? Tohoku J Exp Med (2010) 0.84
Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity. Obes Surg (2013) 0.84
Multiple aneurysms of the inferior pancreaticoduodenal artery: a rare complication of acute pancreatitis. Case Rep Vasc Med (2013) 0.84
Metastatic cervical carcinoma to the thyroid gland: a case report and review of the literature. Yale J Biol Med (2006) 0.84
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model. BMC Cancer (2010) 0.84
Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter pylori infection. BMC Cancer (2012) 0.84
Initial experience with robotic sleeve gastrectomy for morbid obesity. Obes Surg (2011) 0.84
Robotic versus laparoscopic surgery: perspectives for tailoring an optimal surgical option. Expert Rev Med Devices (2011) 0.84
Changes of blood biochemistry in the rabbit animal model in atherosclerosis research; a time- or stress-effect. Lipids Health Dis (2011) 0.83
Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric Cancer (2011) 0.83
Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: associations with clinicopathological variables and patient survival. Int J Biol Markers (2010) 0.83
Barrett's esophagus with high-grade dysplasia: focus on current treatment options. World J Gastroenterol (2011) 0.82
Evaluating the effectiveness of virtual reality simulation training in intravenous cannulation. Simul Healthc (2011) 0.82
Bisphosphonates: prevention of bone metastases in lung cancer. Recent Results Cancer Res (2012) 0.82
Pancreaticoduodenectomy for periampullary malignancies: the effect of bile colonization on the postoperative outcome. Langenbecks Arch Surg (2006) 0.81
Radio frequency ablation (RFA)-assisted pericystectomy for hepatic echinococcosis: an alternative technique. Surg Laparosc Endosc Percutan Tech (2006) 0.81
Evaluation of the effects of laparotomy and laparoscopy on the immune system in intra-abdominal sepsis--a review. J Invest Surg (2009) 0.81
P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian population. Anticancer Res (2008) 0.81
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J Bone Miner Metab (2008) 0.81
Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation. J Hepatol (2008) 0.81
Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection. World J Gastroenterol (2012) 0.81
The contribution of simulation training in enhancing key components of laparoscopic competence. Am Surg (2011) 0.81
Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk. Mol Med Rep (2012) 0.80
Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel. Anticancer Res (2007) 0.80
Thrombotic microangiopathy associated with gemcitabine: rare but real. Expert Opin Drug Saf (2009) 0.80
Surgery for liver metastases from breast cancer. Future Oncol (2015) 0.80
Comparison of erythropoietin and sildenafil protective role against ischemia/reperfusion injury of the testis in adult rats. Int Urol Nephrol (2013) 0.80
Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study. Lung Cancer (2006) 0.80